Literature DB >> 2439705

pp60c-src has less affinity for the detergent-insoluble cellular matrix than do pp60v-src and other viral protein-tyrosine kinases.

D M Loeb, J Woolford, K Beemon.   

Abstract

A difference in affinity for a Nonidet P-40-insoluble cellular matrix was observed between the products of the viral and cellular src genes. It has previously been demonstrated that pp60v-src is associated with a detergent-insoluble matrix containing the cellular cytoskeleton (J. G. Burr, G. Dreyfuss, S. Penman, and J. M. Buchanan, Proc. Natl. Acad. Sci. USA 77:3484-3488, 1980). We observed a similar association of the transforming proteins of Fujinami sarcoma virus (P130gag-fps) and Yamaguchi 73 avian sarcoma virus (P90gag-yes), both of which are tyrosine-specific protein kinases. However, we found that the endogenous c-src product, pp60c-src, was not tightly bound to the detergent-insoluble matrix. This does not appear to have been due to differences in the cytoskeleton between transformed and nontransformed cells since pp60c-src was also solubilized by nonionic detergent in cells transformed by Rous sarcoma virus. This difference in the affinities of the v-src and c-src products for cytoskeletal proteins may contribute to the inability of pp60c-src to transform cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439705      PMCID: PMC255659     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Cytoskeletal elements of chick embryo fibroblasts revealed by detergent extraction.

Authors:  S Brown; W Levinson; J A Spudich
Journal:  J Supramol Struct       Date:  1976

2.  Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src).

Authors:  H Oppermann; A D Levinson; H E Varmus; L Levintow; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

3.  Effects of the src gene product on microfilament and microtubule organization in avian and mammalian cells infected with the same temperature-sensitive mutant of Rous sarcoma virus.

Authors:  E Wang; A R Goldberg
Journal:  Virology       Date:  1979-01-15       Impact factor: 3.616

4.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

5.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

6.  Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.

Authors:  C A Cartwright; W Eckhart; S Simon; P L Kaplan
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

7.  Comparison of the expression of the src gene of Rous sarcoma virus in vitro and in vivo.

Authors:  B M Sefton; K Beemon; T Hunter
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

8.  Immunofluorescence on avian sarcoma virus-transformed cells: localization of the src gene product.

Authors:  L R Rohrschneider
Journal:  Cell       Date:  1979-01       Impact factor: 41.582

9.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

10.  Characterization of a normal avian cell protein related to the avian sarcoma virus transforming gene product.

Authors:  M S Collett; J S Brugge; R L Erikson
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

View more
  11 in total

1.  Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.

Authors:  R R Roussel; S R Brodeur; D Shalloway; A P Laudano
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Characterization of partially activated p60c-src in chicken embryo fibroblasts.

Authors:  M Sato; J Kato; T Takeya
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  p56lck protein-tyrosine kinase is cytoskeletal and does not bind to polyomavirus middle T antigen.

Authors:  R R Louie; C S King; A MacAuley; J D Marth; R M Perlmutter; W Eckhart; J A Cooper
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

4.  CDC37 is required for p60v-src activity in yeast.

Authors:  B Dey; J J Lightbody; F Boschelli
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

5.  Myristylation of pp60c-src is not required for complex formation with polyomavirus middle-T antigen.

Authors:  A Wyss; S Kaech; K Ballmer-Hofer
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Deletions in the SH2 domain of p60v-src prevent association with the detergent-insoluble cellular matrix.

Authors:  Y Fukui; M C O'Brien; H Hanafusa
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

7.  Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Ping Gong; Daniel J Lindner; Simeon E Goldblum; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

8.  Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets.

Authors:  E A Clark; J S Brugge
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

9.  Rous sarcoma virus RNA stability requires an open reading frame in the gag gene and sequences downstream of the gag-pol junction.

Authors:  G F Barker; K Beemon
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  Translocation of pp60c-src to the cytoskeleton during platelet aggregation.

Authors:  A R Horvath; L Muszbek; S Kellie
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.